Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality

Abstract

Background Alcohol is an established risk factor for several cancers, but modest alcohol-cancer associations may be missed due to measurement error in self-reported assessments. Biomarkers of habitual alcohol intake may provide novel insight into the relationship between alcohol and cancer risk. Methods Untargeted metabolomics was used to identify metabolites correlated with self-reported habitual alcohol intake in a discovery dataset from the European Prospective Investigation into Cancer and Nutrition (EPIC; n = 454). Statistically significant correlations were tested in independent datasets of controls from case-control studies nested within EPIC (n = 280) and the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC; n = 438) study. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations of alcohol-associated metabolites and self-reported alcohol intake with risk of pancreatic cancer, hepatocellular carcinoma (HCC), liver cancer, and liver disease mortality in the contributing studies. Results Two metabolites displayed a dose-response association with self-reported alcohol intake 2-hydroxy-3-methylbutyric acid and an unidentified compound. A 1-SD (log2) increase in levels of 2-hydroxy-3-methylbutyric acid was associated with risk of HCC (OR = 2.54; 95% CI = 1.51-4.27) and pancreatic cancer (OR = 1.43; 95% CI = 1.03-1.99) in EPIC and liver cancer (OR = 2.00; 95% CI = 1.44-2.77) and liver disease mortality (OR = 2.16; 95% CI = 1.63-2.86) in ATBC. Conversely, a 1-SD (log2) increase in questionnaire-derived alcohol intake was not associated with HCC or pancreatic cancer in EPIC or liver cancer in ATBC but was associated with liver disease mortality (OR = 2.19; 95% CI = 1.60-2.98) in ATBC. Conclusions 2-Hydroxy-3-methylbutyric acid is a candidate biomarker of habitual alcohol intake that may advance the study of alcohol and cancer risk in population-based studies.

Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort

“…All statistically significant associations in the discovery set (based on P -values corrected for multiple tests ≤0.05) were assessed in the validation set, using the same model and categories of variables as in the discovery set. In this validation set, a more conservative approach was chosen for controlling for multiple tests [ 28 ], i.e., the Bonferroni correction based on the number of tests run for each metabolite.…”

SNP-Target Genes Interaction Perturbing the Cancer Risk in the Post-GWAS

“…There is no risk factor known to have as great an effect on the number of deaths as tobacco exposure. Heavy alcohol consumption is a known risk factor for many tumors including hepatocellular carcinoma, colorectal cancer, breast cancer and pancreatic cancer [ 121 , 122 , 123 , 124 ]. Genetic constitution and environmental exposure are both indispensable causal factors when assessing cancer risk.…”

Metabolomics and the Multi-Omics View of Cancer

“…Likewise, most of the 50+ inorganic, metal, or mineral carcinogens in the IARC lists can be detected, quantified, or monitored via metabolomic methods, especially those that use inductively coupled plasma (ICP) mass spectrometry [179,180]. Similarly, many of the dietary or lifestyle exposures identified by IARC or highlighted in Table 2 of this paper can also be detected, either directly or indirectly, via metabolomic methods [181][182][183][184][185]. More importantly, the molecular effects and the molecular consequences of these exposures on cells, tissues, or biofluids can also be characterized via metabolomics [186][187][188][189].…”